Public Accounts Committee

Oral evidence: Integrated Care Boards: re-organisation, HC 783

Monday 16 November 2026

Ordered by the House of Commons to be published on 16 November 2026.

Watch the meeting

Members present: Sir Geoffrey Clifton-Brown (Chair); Mr Clive Betts; Al Carns; Anna Dixon; Rachel Gilmour; Tristan Osborne; Matt Turmaine.

Abdool Kara, Executive Director, National Audit Office, Andy Morrison, Director, National Audit Office, and David Fairbrother, Treasury Officer of Accounts, were in attendance.

Questions 1-92

Witnesses

I: Samantha Jones OBE, Permanent Secretary, Department of Health and Social Care, Sir Jim Mackey, Chief Executive Officer, NHS England, Elizabeth O’Mahony, Director General, Finance, Department of Health and Social Care, and Jan Thomas, Executive Director for System Development, NHS England.


Report by the Comptroller and Auditor General

Restructuring of Integrated Care Boards (HC 620)

 

Examination of witnesses

Witnesses: Samantha Jones OBE, Sir Jim Mackey, Elizabeth O’Mahony and Jan Thomas.

Chair: Welcome to this session of the Public Accounts Committee on Monday 16 November 2026. Today, we are examining the restructuring of integrated care boards, which plan and fund the NHS services for their local populations. Their role in commissioning the right services is vital to improving people’s health. In 2025-26 alone, they were responsible for £171 billion-worth of expenditure in the health service.

NHS England has set targets for the ICBs to cut costs by 43%, saving £908 million a year. It is estimated that achieving that will require about 8,000 fewer posts—roughly a third of the existing ICB workforce before cuts. The recent National Audit Office Report found that restructuring has moved at pace, but that supporting arrangements have not kept up. Important questions remain about ICBs’ future responsibilities and whether they will retain the skills and capacity that they need.

This Committee has repeatedly questioned officials about ICB reform, so today’s session is an important opportunity to test what assurance the Department and NHS England can now provide. We will examine how workforce reductions and mergers are being managed, and whether savings will be sustainable without weakening services or partnerships with local government. Above all, we want to know how the Government will demonstrate that the changes improve outcomes for patients, rather than simply reducing administrative costs. We have a very senior cast with us, including the permanent secretary and the chief executive. Permanent secretary, will you introduce yourself, and then will you, Sir Jim, introduce yourself and the two officials you have brought with you?

Samantha Jones: Hello. I am Samantha Jones, permanent secretary at the Department of Health and Social Care.

Sir Jim Mackey: I am Jim Mackey, chief executive of NHS England.

Jan Thomas: Hello. I am Jan Thomas. I am the exec director for system development with NHS England. I am also an ICB chief executive, for the central east ICB.

Chair: Finally, Elizabeth, you are very welcome back to the Committee. Will you introduce yourself?

Elizabeth O’Mahony: Thank you. I am Elizabeth O’Mahony. I am the director general for finance at the Department of Health and Social Care and CFO for NHS England.

  1.              Chair: Thank you very much. You kindly sent us an additional brief, permanent secretary—I think last week. Since then, you have even sent us a letter updating that, on 16 November. Basically, the letter answers the first question that I am going to ask you, but it would be really helpful if you could just summarise the letter so that we can get it on the record. The question, arising from the additional information, is: do you have any updates for the Committee on your estimates of the cost of the reorganisation associated with the abolition of NHS England? It is all set out beautifully in that letter, but if you have it can just tell us what the answer is—or can do so from memory—I would be grateful.

Samantha Jones: I long ago learned to make sure that I have my expert sitting next to me, and the DG for finance is here. Are you comfortable with my asking her about that?

Chair: That is perfectly acceptable.

Samantha Jones: As we outlined in our letter, the overall estimated cost of reducing the number of people working in the centre is approximately £1 billion to £1.3 billion. That is slightly dependent on the experience—I was going to say age—of the individuals involved, for the actual final cost, but we are on track to deliver £1 billion-worth of savings over this Parliament.

Chair: Thank you. You hope to make savings of £1 billion; we will question you on that in a while.

  1.              Anna Dixon: When we last met, I asked the top-of-the-session question, and you pointed forward to the Secretary of State’s statement, which has now happened, on how you were going to manage at the centre, the redundancies and restructuring of NHS England and the Department of Health. Could you outline for the Committee again, following that statement, how you are going to deal with the pay discrepancies at the most senior level, between some of the NHS staff, particularly those in regions, and the Department of Health and Social Care? I should have put it on the record, as a conflict of interest, that I was working for the Department of Health and Social Care in 2013, when NHS England was created.

Samantha Jones: I think the Secretary of State also set out in her letter to Committee members that, subject to the passage of the Bill, NHS England will be abolished on or after 1 April next year, and the vast majority of NHS England’s functions and staff will transfer to the new Department of Health and Social Care. We are calling it the new Department of Health and Social Care because it needs to look different and do something different as a result—otherwise, we would have lost the sense of purpose.

The reason for the abolition of NHS England and the change that was set out is to ensure that we have a very clear “national”—what is the role that only national can do, from a national strategy perspective? However, that should be in line with the Prime Minister’s ambitions and requirements around devolution, and as much as possible should be delivered locally, as close as possible to local places and local people across ICBs, and of course with colleagues in local government.

To do that—to get to the answer to your question—the Secretary of State, subject to all the appropriate parliamentary processes, has set out that there will be a transitional special health authority, which will be hosted within the Department of Health and Social Care and headed by an NHS chief executive and will house the regional functions of the NHS. She has been very clear that the purpose is to keep delivery as close as possible to and within the local NHS and, importantly, enable staff to move in and out of the NHS, because we need people who have experience of running things from the NHS, within the NHS.

You will forgive me, because some of this is still subject to negotiation with the unions and to final confirmation, but we have an agreed set of measures—I will not outline them to the Committee today, because we are still going through conversations with the unions—making sure that we can support the terms and conditions, as appropriate, of people moving in and out of the NHS.

  1.              Anna Dixon: Do you want to add anything, Sir Jim? Back in 2013, there were analysts who left the Department of Health and went to NHS England; they were doing the same work but getting paid more. That pay differentiation will now have opened up, because one group has been constrained by public service pay increases and the other has been subject to NHS pay increases. If the HSJ article is anything to go by, there remain people doing the same job, at the same grade, but on very different pay. Is this how you are solving the problem?

Sir Jim Mackey: As Sam said, there will be an approach to pay harmonisation for colleagues moving into the Department. That will be agreed through the unions, through a proper process, so we cannot get into that today. I would say, on the HSJ thing, that there is more to this than headline pay. Pension contributions and other things need to be taken into account as well, so the disparities are not as big as they at first look, in the way they were portrayed there.

On the special health authority, in the last few weeks, there have been an awful lot of comparisons to pre-2012. Regions are more like SHAs were in 2012, and they were in the NHS. People were moving in and out more, within the NHS. We are trying to keep them more pointing into the NHS rather than the core Department, especially as we develop the devo model and work out how things need to work with other parts of the public service. The idea was to draw a ring around those people there. Most colleagues will go into the Department, and then there will be the normal process—this will be negotiated through the unions—about harmonisation.

  1.              Chair: When you have concluded those negotiations with the unions, will you let this Committee have a full answer to Anna’s question?

Samantha Jones: Yes.

  1.              Chair: This is the obvious question, and you may not be able to answer it, but when do you expect the negotiations to be concluded?

Samantha Jones: It is—[Interruption.]

Chair: You do not have to answer if it is difficult.

Samantha Jones: It is going to take as long as the negotiation takes, but clearly we need clarity prior to 1 April. I will come back and confirm once it has concluded.

Chair: That is fully understood. Thank you.

Sir Jim Mackey: It is done through the processes that apply with TUPE. There is a natural process that has to be followed, and that is just about to start.

Chair: I fully understand that they are sensitive.

  1.              Rachel Gilmour: There is a degree of cynicism about new authorities and institutions set up by Government, which I completely understand. To what extent is the new special health authority just a new layer of bureaucracy between the chief executive of the NHS and the rest of the health service?

Sir Jim Mackey: I understand the cynicism. We have had a lot of discussions about layers and trying to simplify things, but in the end, there is quite a strong view that things were not perfect in 2012, which I mentioned, and since then we have got very complicated. I think most people in the service would say it got very complicated and very costly. The health service performed better at that time. There were other factors—the levels of growth and stuff—but we have tried to go back to a model that is more akin to that and update it where we can.

The special health authority thing is partly about allowing colleagues to move in and out of the service, where that is their job. They are much more local than they are central. This devo thing is important for how we work out which parts of the NHS work with strategic authorities and councils, and in place, et cetera. It is a mechanism to say that while we work all that out over the next couple of years with other parts of Government, special authorities are by definition time-limited, which is why it is determined as transitional.

There was a period in the NHS plan process where we considered whether to create regions as specific legal entities, but decided at that point—to your question—that we have had too many bodies and too much complexity. If this is about trying to simplify, we should not do that.

  1.              Mr Betts: It is a temporary body, then—that is very clear.

Sir Jim Mackey: Yes.

  1.              Mr Betts: It has a limited life expectancy. How limited?

Sir Jim Mackey: None of us can or want to put a specific time limit on it, mainly because—I am sure we will get into this—alignment with mayoral authority boundaries will still take a bit of working through. If that takes two years, we will need time for this to work through. Rather than set an artificial deadline of a certain number of months or years, we want to work it out over a period of time. It is not permanent, not for ever, but it will not disappear three months after it started.

Samantha Jones: As the Secretary of State very clearly set out, it maintains focus on delivery and support within the NHS for people who deliver care on a daily basis. While we go through the transitional process around devolution and making sure we are in line with where we are trying to get to, as set out by the PM, it does maintain a really important focus for the NHS around delivery, and I think everybody would support that being the case.

  1.              Mr Betts: I can hear that, but if I was a senior official looking at a potential vacancy or being moved to a particular vacancy in this new special authority, I think I would ask the question, “How long am I likely to be here for?”

Sir Jim Mackey: I met colleagues in Liverpool on Thursday on a visit to the north-west region. Generally, I think regional colleagues—I hesitate to say this—are possibly less anxious than they were before, because at least they can see they are in the NHS bit. There is not the pay harmonisation and centralisation risk of being in the Department. But nobody has any guarantees about anything anymore. They understand that there is a period, especially going back to last week, when the devo thing is a live, palpable thing in that area where they can see we have work to do to get proper alignment across the public services. Again, we will probably cover these changes.

I should put on record that none of us was happy or enjoyed the uncertainty and discomfort for colleagues last year. ICB colleagues have put up with an awful lot of stress and distress through this process. We are all sorry about that. It took a long time to get certain things agreed. I am sure that will come out through the discussion, but it is a change that was necessary partly for operating model purposes, but also partly financial. We started last year with a planning gap of £6.7 billion—£4.5 billion off the deficit support—and it has made quite a significant contribution towards addressing the financial position overall.

So, I think there is an understanding in the round of all these things. It is a big, complicated change. But we should recognise that most of these colleagues—regional and NHS England colleagues—have been reorganised a lot. There are some here who have been reorganised a lot. I have talked to a lot of colleagues who say it is the sixth time in eight years, and that is true; there has been an awful lot of churn. Over the next couple of years, we are hoping to find a model that has got more longevity in it.

  1.         Mr Betts: Is the likelihood that many of the staff working in the special authority will eventually migrate into the mayoral combined authorities to provide the support needed there for the new health role we are going to have?

Sir Jim Mackey: It could be in parts of the country, but there could also be things that we currently think about as being in regions that might get devolved into ICBs or vice versa as we work the model out.

Basically, we have tried to put a ring around it. We set off on this last year; quite a lot changed throughout last year and then it has changed a lot this year on the back of the devo direction and so on. Let us all understand that there is a degree of fluidity about it, but hopefully, because of the really significant reduction that has already been achieved, there is less pressure for this to be about headcount reduction and cost reduction.

Mr Betts: I am still a bit confused, but never mind.

Chair: We will come back to that. We need to keep going because we have a lot to get through.

  1.         Anna Dixon: I think we are getting to the core of the hearing now, in terms of the focus on the ICBs and the subject of the NAO Report. Sir Jim, thank you for recognising that for those affected by the headcount reduction it is obviously a difficult time. I have staff in my constituency who work in NHS England and the uncertainty is very real, as it is for those in ICBs.

There is some cynicism that a lot of this was about cost reduction and headcount reduction. Can you balance that out by telling us what the benefits are expected to be for local populations when this ICB restructuring finally completes, and perhaps explain what is meant by “strategic commissioning”?

Sir Jim Mackey: I will bring Jan in before I get into too much trouble in trying to answer that question, but there were a number of drivers, as I have said. There was a financial imperative; we were facing a really big deficit last year. We looked at trusts and their corporate costs, and NHS England and ICBs obviously shrank dramatically as part of a big cost correction. That was absolutely one of the factors.

Confusion over decision making was also a very live factor—whose job was it to make certain decisions? There was a very strong view expressed from the provider part of the NHS that said, “This is really complicated. I am having a meeting with all these people, and it feels very imbalanced and out of control.” Some of that came out in Lord Darzi’s report.

We felt strongly that the NHS needed to move more quickly and try to improve more rapidly. We need to try a delay and free people up as much as we could—to strip things back and make it a bit clearer and tidier. It was about all those things at once; it was not one dominant thing.

We met with ICB chief execs last week to check what the reality is and how this thing is working. They were unanimously positive about that fact that it was painful—it was a very difficult year that nobody would want to do again—but it has clarified things and allowed them to focus more on strategic commissioning and putting more of their resources in the right place. They were starting to see signs of things coming through. I have been deluged since with examples of, “We have done this. We have achieved that”, which I can share with you at some point. I can send you a note on that, if it is helpful.

The whole question of “What is strategic commissioning?” is starting to come to life. It has gone from being an abstract concept with a very confusing set of functions to something that feels clearer and has more direction.

Jan Thomas: If you think about the four core functions that ICBs were set up to do, you start with how you will improve outcomes, tackle inequalities, and make sure you get value for money and enhance productivity, and then you really go to how you make sure you get that wider social support and economic benefit. That is why we started.

I think we were very tactical with ICBs. It was very, “How do we plan for this year, what resources do we have, how do we get through the next year before we move on?” The way I describe it is, we were working in a land where we had lots of people coming to us and saying, “I can prove to you that this is a really good thing to do,” and as an ICB leader I would say, “That is brilliant. You have got something great that you want to show me, and you can prove it works.” The question we needed to ask was, “If I only had £1, where would I spend it next?” and not, “Can you prove that, if I give you £1, you will spend it well?” When talking about strategic commissioning, and when speaking to my 24 ICB colleagues, we are asking, “How do you prioritise?” rather than doing strategy that sits up in the ether somewhere, looks down and sets the direction. Are we investing in the right things? Are we really making the next wise decisions and how we are getting that focus?

In terms of one of the things we had not done in the past but are doing now, we have groups of our population—our residents—who are very high-risk, because they have high needs; they are very vulnerable in our communities. We do not pay any more attention to somebody who is high risk and think, “How do we keep it there?” as a commissioner, because we commission services. If you have people who are quite risky—for example, they have cardiac that could get worse—we want to be able to avoid that, so what are we doing to avoid that risk? We are not talking about services, but what am I going to do to stop people who have high cholesterol getting worse—

  1.         Anna Dixon: I am sorry to interrupt, because that is very interesting, but we know the theory of this strategic commissioning. Why has it taken reinventing something in 2026 to get ICBs to do something that should always have been their thing—to look at the population and use the money they are allocated to maximise the health outcomes for that population? Can you try again and say what the expected benefit of this ICB structure is? I think, Sir Jim, you were getting there in saying that it is more focused.

Jan Thomas: Apologies. Just because we said it was happening in the past does not mean we were doing well enough. There is a skills and capabilities gap that we are now addressing to make sure we are now actually able to do things we talked about in the past, with things like the strategic commissioning development programme we are putting in place. We should be careful in saying things; we have been saying lots of stuff, but the difference now is that we have 25 ICBs really committed to how we will hit different metrics to demonstrate change. That is different from before. Can I give you an example?

Anna Dixon: Briefly.

Jan Thomas: The ICBs have come together, and we have a key set of five utilisation metrics. They are committing to say, “What are we going to do differently to shift these metrics, together, across the country?” It is a tangible move to make sure we are doing things like reducing the amount of first out-patient appointments and the utilisation of ED. We have done those things before in pockets. The difference with this is that we are doing it collectively so that we can move the numbers quicker, together, than we did before.

Anna Dixon: I think colleagues will ask more about metrics, but I will hand back to the Chair.

Chair: Thank you, Anna. We are delighted to have Al Carns as our new member today. He would like to ask a question.

  1.         Al Carns: I note that since June 2026, 3,000 staff have left ICBs through redundancy. When you are transforming big organisations such as NHS ICBs, or in defence, sometimes it drives perverse behaviours. Are you keeping a tally or track of what grade those redundancies are coming in at? Is it driving any perverse behaviours in the redundancy and efficiency model?

Sir Jim Mackey: I will start, and then Elizabeth will pick that up. We discussed this with ICB chief execs last week, challenging ourselves specifically on whether we are creating organisations with the right capability to do what is required in the future, rather than chasing the immediate headcount and cost reduction. Chief exec colleagues were very clear that it is a complicated change. They have had to adapt a few times. They are getting there, but it is not perfect yet. A few articulated that they could feel that they had capability gaps in certain areas, while another articulated that they maybe had a capacity imbalance, where they had a bit too much resource in one area and wanted to put it in another. It felt live and like work in progress.

We are keeping an eye on it to make sure that we do not get any big distortions in the structure and the cost structure. Without loads of oversight, we are regularly keeping an eye on it and asking, “This hasn’t just exploded again, has it?” so that we do not suddenly end up way above where we were or with something unforeseen happening. I was assured after our conversation last week that colleagues felt much more positive about being more equipped to do the job. Frankly, I am heartened by their honesty in accepting that they are not perfect yet. They are not in the right place yet and there is still work to do, but they could articulate what they were doing about that.

Elizabeth O'Mahony: It is about 8,000 leavers by August 2026, of which 4,200 are voluntary redundancies, approximately 230 are compulsory redundancies and about 3,000 are leaving for other reasons, so natural attrition or vacancies that were pulled. Throughout the process, through ICB boards—obviously, boards are overseeing the process—there has been a quality impact assessment to understand grading and mix. Across certain functions, such as financing, contracting and commissioning, we have all kept a close eye on making sure that we do not lose the skills from the core capabilities.

To go back to Anna’s point, we were looking for change perhaps more in the performance management space, as that function fell away. Where core skills were being retained within the ICB, we kept a close eye on what was happening. As Jim has described, ICBs actually report on a monthly basis on where they are against their costing and structures. Essentially, at month 7, month 9 and month 12, we will do a deep dive into those numbers.

  1.         Al Carns: To close this off, I think it is less to do with the finances and more to do with whether it is driving perverse behaviours within the ICBs, and whether it is replacing the right grades, and upskilling and downskilling, as required.

Elizabeth O'Mahony: Sorry; when I mentioned finance, I meant the finance teams. The core responsibilities for the ICBs going forward include strategic commissioning, and I was referring to the staff in the financing and contracting teams, as those roles have changed, rather than just the finances.

  1.         Al Carns: So are you collectively keeping oversight of that at your level, and making sure that there are no perverse behaviours across the ICBs? Do you have a holistic view?

Sir Jim Mackey: Yes. Through the oversight framework, we have a good eye on ICB colleagues, largely through regions as well, just to make sure that we are confident in not only the metrics but that we are starting to deliver what we need to do, and that it looks like strategic commissioning is coming to life. We have the right board capability, and the organisation is feeling fit for purpose, which is a key part of the oversight.

To go back to Anna’s question on the functions of the ICBs, an ICB chief exec, not long after they were appointed a few years ago, said to me, “I’ve got this job, and I’ve got all these things that I’m supposed to do. I don’t know how we’re going to deliver all these things.” They felt very driven to deal with the performance management and to leave commissioning, because it was not possible to do them all. That is partly what we have been trying to do. We have been saying, “There are other people doing performance management, but we are going to handle it in a different way. You focus on this commissioning thing.”

Samantha Jones: If you are comfortable, Chair, it might be worth us explaining how we are picking up the capabilities.

Chair: I am just a little bit conscious of the time, so we have to speed up a little bit.

  1.         Mr Betts: It seems a wonderful world, doesn’t it? We are saying to patients, “We’re going to get rid of all these staff and give you a better service.” It doesn’t feel quite right, does it? Most people just would not believe that that will be the case.

Sir Jim Mackey: Part of the argument, Clive, is that we were trying to protect staff who were dealing very directly with patients every day and caring for them. However uncomfortable it was, we targeted the headcount reduction and cost reduction at the layers that were not directly on the wards or in the clinical departments—on the shop floor, so to speak.

  1.         Mr Betts: So those staff were not actually doing anything in the services for patients.

Jan Thomas: No.

Sir Jim Mackey: Not in terms of direct, hands-on patient care.

  1.         Mr Betts: They were sat there, taking a salary, but providing no benefit.

Sir Jim Mackey: Well, they were providing support services.

  1.         Mr Betts: You said no, so that means there must be some benefit or services being lost, doesn’t it?

Sir Jim Mackey: We are agreeing that they were not providing direct, hands-on patient care. What we have tried to do, as part of the overall financial correction, is take money out of the parts of the service that are not doing that, and to protect that as best we can. We can show—the Report shows—how much money is being released to increase the amount of resource available for patient care.

  1.         Mr Betts: Nevertheless, staff are going who were being paid over a long period of time to do something in the NHS, and we are now saying that the something was not worth anything for patients.

Elizabeth O'Mahony: Quite a lot of it was being duplicated, particularly in performance management. In my previous role, I was quite often engaged in conversations with ICBs where they were doing things that were being duplicated at the regional level, as well as sometimes in provider collaboratives. It was a duplication that we have actually reduced. Going into this, there was obviously wide variation in the volume of running costs and administrative costs in ICBs, but there was not an obvious benefit of that in patient outcomes. We have looked to address that.

  1.         Mr Betts: Looking at all the staff who are going, are we saying that the vast majority were doing things that other people somewhere in the NHS were doing?

Jan Thomas: There are different groups of services that ICBs provide. Continuing healthcare, for example, is very hands-on, with clinicians making sure that we are following the framework. There is a group of people who are hands-on delivery, and our medicines optimisation, safeguarding and SEND functions have been protected a lot through this process because they are patient—

  1.         Mr Betts: Additional money has been put in for that, hasn't it?

Jan Thomas: As we have been redoing this, we have been putting more in to make sure that we can stabilise that. Then there are other services. The biggest change has been on service redesign. We had lots of staff doing service redesign. What we want to do is move that, with the providers working together and using their clinicians and teams to do that. It is not just about performance management; it is how we get the change to the pathways. Instead of people sitting in ICBs trying to make it happen, we want to give more of the levers to the providers for them to do it, and that frees up staff.

  1.         Mr Betts: The providers are going to take on work.

Jan Thomas indicated assent.

Mr Betts: This was not work that they were already doing; it was work the ICBs were doing and the providers were not. Is that right?

Jan Thomas: It was always “with”. However, what we are trying to do through this, if we think about those functions like pathway redesign, it is much better to get the people running the services and the clinicians to do it. That is what we are trying to liberate. Before, the ICBs and commissioners were, I think, trying to do that to people; what we are trying to do now is create incentives and levers to help them do it.

  1.         Mr Betts: I do not disagree with that. What I am asking is whether the providers were doing it anyway, or whether this is an additional responsibility that you are giving them.

Sir Jim Mackey: They were largely doing it anyway, either themselves or through provider collaboratives. Elizabeth and Jan both made the point that ICBs were involved in it. We  took the view that providers, with appropriate direction, could get on and do that because they owned the clinical staff. The clinical staff were working in that environment anyway, which is where most of the action needed to take place.

  1.         Mr Betts: Essentially, much of the work that was being done by the people who are now being made redundant or moved on in ICBs was being done anyway by someone in the providers.

Jan Thomas: We are reducing the duplication and are effectively trying to find different ways to do it.

  1.         Mr Betts: Most of the work that was being done by people who are no longer going to be there in the ICBs was being done anyway by people in the providers.

Sir Jim Mackey: It is not just providers, as has already been said. Quite a lot of it was in performance management, which was already being done at a regional level. If you had a provider in trouble, the ICB would have had a performance layer at region and then often at national as well. What we are trying to say is, “Let’s just thin this out and release the cash.”

  1.         Mr Betts: I know that you are going to talk to me, Sir Jim, and thank you for coming back to me about the situation in South Yorkshire. If I push hard, I should be able to be told that the staff who have been lost at the ICBs were actually doing work that was being done in providers or at regional level, and therefore those elements within the NHS can step in and do that work without any effect on patients.

Sir Jim Mackey: Largely. Your specific issue around teams of people in place and whether you have access to named individuals and so on was one of the things we talked to ICB colleagues about last week. One—who I will not name—described inheriting a system where they had many organisations and many dozens of people in place. They thought that that was wasteful and that there was a different way of dealing with it. Some accepted that they maybe needed to go back round the place management, because they had not quite got it right. On your challenge, maybe there was not enough of a personal relationship with other partners in place. It is a work in progress.

  1.         Mr Betts: And you are going to come back to me on that point.

Sir Jim Mackey: Yes.

Mr Betts: I appreciate that.

  1.         Chair: My hearing is not brilliant today, but can I sum up what I think the answer to Mr Betts’s question is, and make sure that I have understood it correctly? You are getting reductions in budgets through efficiencies within the ICBs themselves, through clustering and mergers; you are transferring some of the services, particularly on quality assessment, to the individual providers themselves; and some of the work is being hived off to regional offices, and some to local authorities. Is that basically what is happening?

Sir Jim Mackey: I do not think we mentioned local authorities, Geoffrey. Also, on the hived-off bit, there were things that were already being done by those people. We are trying to get to a world where there are not two or three tiers doing the same thing and are trying to simplify it as much as we can.

Chair: Thank you very much.

  1.         Mr Betts: Just to conclude, when will we see a clear measure of the improvements that have been brought about? We would hopefully have an assurance that there have not been any adverse outcomes.

Sir Jim Mackey: This is what I suggested earlier. I got a deluge of positivity from ICB chief execs the other day who had examples of things they can show they have improved in the period since all these changes were made and in making these improvements this year. I am happy to get that put into a document to share with you privately.

Chair: That would be very helpful.

Sir Jim Mackey: Some are very specific and localised, but it gives you a feel that they are actually doing things.

  1.         Anna Dixon: That would be very welcome, but for public reporting it would be ideal to have not just case studies of what is going well, but a more systematic tracking of benefits realisation, for want of a better phrase, alongside the cost reductions and headcount reductions we can see. Maybe this comes back to you, Jan: what work are you doing across the ICBs to report measurable metrics and benefits of this more focused approach to strategic commissioning?

Jan Thomas: There are two things. First, there is the national oversight framework that we are just now refining. There were 38 measures in that, looking at everything from health inequalities to utilisation, and we are doing some final tweaks to it for ICBs. It will effectively give you a comparator across them—that will be the first thing.

  1.         Anna Dixon: When is that being published?

Jan Thomas: We are finalising it now. We have not confirmed the date, but it is due to come out, and we are refining it for ’27-28.

The ICBs have come together to make sure that they can answer these kinds of questions, and they have committed to move five metrics themselves as a collective to make sure that we can show how our decisions and actions on our specifications are making a difference. Those five metrics are utilisation of emergency department per 100,000, clock starts per 100,000—

  1.         Anna Dixon: What is that?

Jan Thomas: Clock starts are how many times someone is referred to out-patients—effectively putting them on a waiting list. How are we doing that? How are we reducing length of stay for people over 65, our most vulnerable? How will we keep increasing the access to dentistry for children specifically? How will we keep increasing the access to same-day emergency care? They are five utilisation metrics, but you have to do the health inequalities and the other things to get them right.

  1.         Anna Dixon: Forgive me; I was going to leave it at that, Chair, but one of the main things you said was that duplication of performance management will not be an ICB thing, yet quite a lot of those sounded like waiting time-type target measures—you called them “utilisation”. How does this shift toward a focus on health inequalities and improved outcomes? Those just sounded like duplicating performance management.

Jan Thomas: I will use the word “utilisation”. In the past, we had moved away from looking at demand management, as we did before. We now have lots of cumulative commissioning, so you have services layering on services. We are trying to make it clearer that we want the left shift to happen through things such as neighbourhoods, by making sure we are reducing the number of people going to emergency. It is not actually about emergency; it is about all the left shift we have to do to achieve that. You cannot achieve that without the left shift. We are using those as utilisation metrics to push neighbourhood delivery and all the other work we are trying to do.

  1.         Anna Dixon: So they are like canaries in the mine.

Jan Thomas: Exactly.

  1.         Anna Dixon: If that is going wrong, it is because the whole system is doing something wrong. By observing that metric, you think they will take a whole-system response to it, rather than do what we saw last time and throw money at just one problem.

Jan Thomas: You cannot shift all of those at the same time without having done the left shift.

Anna Dixon: Okay. Perhaps you could alert us when the new national oversight framework is published. We look forward to it.

  1.         Tristan Osborne: I will ask a series of questions about your programmes and who is managing that centrally, and about some of the timings and where we are with the operating models raised by the NAO. I am assuming that there is a central team that manages this; in the private sector, you would have a change management function.

Given some of the outcomes in the Report around the delays to changing target operating models, have all the ICBs reported their operating models to you and the progress they are making around reductions?

Sir Jim Mackey: Yes. Jan, do you want to go over that?

Jan Thomas: We had 45 ICBs before we started this. Come April this year, we had 36 ICBs that had then done a change process. Within that, there was a series of gateways that we had to go through between board assurance and reporting up to regional and national colleagues to give them assurance that we were able to fulfil our functions. Those 36 ICBs are now working as 25 ICBs, because in some places there are multiple ICBs with one leadership team over the top. Each one of those is being managed. We are now doing the work to look at what we have previously mentioned, which is what happens when we have further devolution and mayoral strategic authorities.

  1.         Tristan Osborne: If I can just ask the question again, has each of those 25 come back to you on its target operating model that it will deliver? Have they all confirmed what they will look like?

Jan Thomas: Each one has done an assurance process to say that it is able to fulfil its capabilities. That has been assured by regional colleagues, so we have a view and we have all the detail from their operating plans on what they will deliver.

Tristan Osborne: That was partly a yes, but I am not sure that that was an entire yes.

Sir Jim Mackey: Can I just add to that? There was a national project board, effectively—the model ICB project board—that morphed a couple of times through the year and was initially led by Sir Glen Burley. Jan now runs that part of the national infrastructure. There were a lot of moving parts, and it was our job to keep an eye on whether people were moving in the right direction but also, as best we could, to make sure that we did not drop the ball between changing something in an ICB and changing something over in a region. We did not get that right all the time, but that was part of the job that was being done.

  1.         Tristan Osborne: Just to follow-up on that, are all the ICBs responding in a timely way? Throughout this Report, there seems to be piecemeal data where some ICBs are reporting and others are not. Can I confirm that each ICB is reporting in a timely way and not missing deadlines?

Sir Jim Mackey: Yes, absolutely. We have recently been around this with them to make sure that, as well as delivering on their capability, they are in line or on track in terms of their target cost—the cost per capita that we give everybody for their running costs and so on. They are all reporting in the normal way on their performance and financial position.

  1.         Chair: Tris, just before you go on, can I ask a really important question on this subject? Paragraph 3.25 on page 49 says, “All but one ICB provided the assurance that they would have the structure in place to perform their role efficiently and effectively.” Can you tell us about the remaining one? Do you now have all the ICBs? The work for this Report was carried out between April and October this year. Do all the ICBs, including that one, now give you that assurance that they can perform their role effectively and efficiently?

Sir Jim Mackey: As far as I am aware, but we will double-check and come back to you.

Chair: I think we need to know why there was that one.

Elizabeth O’Mahony: There was one ICB—a London ICB—that clustered late, so it has been later in the process. There is one clustered ICB that is currently reporting that it will deliver its running costs by the end of the year, whereas others have accelerated and can already give us that confidence. We will review that at month 7 and at month 9, and if there is any danger that it will miss the target, we will obviously work closely with it.

Chair: Okay. Thank you. Sorry to interrupt, Tris.

  1.         Tristan Osborne: I asked my question because we have confirmed that the target operating models are in place, but it says in paragraph 3.8 that you are not collecting future projections of ICBs’ redundancies. Given that they have target operating models planned, I am assuming that it is a bit strange that they have not projected what those redundancies will be and why you are not aware. In 3.10, it also mentions, “Slower-than-planned progress on developing new operating model”. I suppose my question is, how much confidence do we have that we will not see slippage around future cost reductions? I will talk about redundancies as part of that process.

Sir Jim Mackey: As has just been said, we have been through an assurance process where they have all confirmed that they are either already on track and have it in the bag or are confident that they will be by the year end. We will keep it under review, but we are not worried that some are so far behind. For most of them, this is behind them: they have made their restructure happen and incurred the cost of redundancy and so on. Looking forward, we are not expecting or anticipating large additional redundancies.

  1.         Tristan Osborne: Okay. Talking about redundancies, obviously paragraph 3.8 talks about the expected redundancy numbers being around 8,200, with 71% being voluntary redundancies. If we look at figure 13, the large bulk of redundancies thus far have been voluntary. By my estimates, 29% would be compulsory, yet that is not seen in the figures. I am assuming that there is a more difficult compulsory redundancy programme that is likely to be seen in these figures going forward. Is that correct?

Elizabeth O’Mahony: In aggregate, we are close to delivering the target without any further redundancies. I would anticipate that any further redundances at an ICB level will be more around reshaping.

  1.         Tristan Osborne: Forgive me—when you originally presented the estimates, you said that 71% would be voluntary. That leaves 29% that are not voluntary, but that is not what we see in figure 13, where the huge bulk are voluntary. Will we likely see those compulsory redundancies in the next wave of projections?

Elizabeth O’Mahony: No. We are almost at the target reduction, and we have also seen quite a lot of natural attrition, through people leaving because they have chosen to go to other roles. I am not expecting a big increase in redundancies at an ICB level between now and the end of the year.

Sir Jim Mackey: There was more concern about the risk of compulsory redundancy at the beginning and during the process, but as the process developed, many more colleagues took voluntary than was originally anticipated.

  1.         Tristan Osborne: From your answers, it sounds like there is a necessity for future projections for redundancies—in fact, you have just given me the projection that going forward, you are not expecting a huge number of compulsory redundancies. The recommendation says that “NHSE does not collect data on ICBs’ future…projections”. You have given me an assurance, but if you have not actually collected the data, what are you basing that assurance on?

Elizabeth O'Mahony: The target reduction was, in aggregate, 8,000 across the programme, and we have had 7,753, I think. We continue to see people choosing to leave as we are reshaping, so we are not expecting a big redundancy programme. What we are collecting is data on ICBs’ confidence on delivery of their running costs; in that envelope, they are confirming to us that they will meet that. If they need to do extra redundancies, that would be within the affordability envelope, so there are not additional costs associated with that.

  1.         Tristan Osborne: Lastly on redundancies, should you be collecting that data? It says in paragraph 3.15 that at the moment, you do not collect the data to give future projections, but you have kind of given that already.

Elizabeth O’Mahony: We do not collect it for future projections, but we ask people for confirmation that they will live within their financial envelope, and that they can deliver against the core standards and things that we are asking ICBs to deliver against. We will report the redundancies on an annual basis, in the annual accounts. Obviously, they get clearly audited.

Sir Jim Mackey: It is also a responsibility of ICB leaders to flag and tell us in advance about a major change programme that might involve redundancies. That would happen through the regional system; national colleagues would be involved if necessary. Going forward, this should now be business as usual; there are no more natural change processes within organisations. But we absolutely expect that if somebody is going to make a change that involves several hundred potential redundancies, we would know about it—they would flag and report it, and we would work with them on it.

  1.         Tristan Osborne: Thank you very much. We would be keen to see where each ICB is in relation to its target operating model to confirm that they actually have those in place. That was a clear point in the Report. If you could send us that information, it would be really helpful.

Sir Jim Mackey: If it is helpful, we can give you a table that shows, by ICB, levels of confidence on assurance of the model and on whether they can live within the cost per head.

  1.         Chair: That is very important, Jim. To dig down into Tris’s questions, he referred particularly to the table in figure 13, but looking back at paragraph 15 on page 10, up to June 2026, you made 3,700 staff redundant. That is out of 8,000, so there is still a long way to go. That 3,700 cost you £582 million. If we extrapolate that to the 8,000, the total cost would be £1.258 billion, so I am not quite sure where the estimated saving of £908 million is coming from. We need to have a note on that, please.

Could that be accompanied by a detailed note on redundant staff being immediately re-employed in the health service? I am not sure that the regime I see in the NAO Report is strong enough, particularly as it looks as though in some categories, after a month, they can get a job in the health service and not have to pay their redundancy back. Rather than take up time on that at the moment, could we have a full note on all that, please?

Sir Jim Mackey: Yes, absolutely.

Elizabeth O’Mahony: I think a note would be helpful because there was £582 million-worth of redundancy costs in the accounts, which included provisions for some people who had not left because there were things like pension estimates and other things.

Sir Jim Mackey: That was to the end of March.

Elizabeth O’Mahony: I think that we have different time periods as well, so it might be quite helpful to work though that in a table, as you say.

  1.         Chair: Paragraph 15 and the table in figure 13 do not seem to quite reconcile with one another, because I do not see how you will get to that 8,000 without a considerable level of compulsory redundancies.

Sir Jim Mackey: We are confident that this is all reconcilable. We are talking about different numbers at different periods, but we will draw that out in the note and pop that over.

Chair: Okay. That is really helpful, thank you.

  1.         Tristan Osborne: I think the Chairman has adequately discussed the expectation. Let me follow up on what Clive was suggesting. In relation to the third entry in figure 11, ICBs answered—although it was only a proportion of them—on statutory functions that they believe would be implicated by this restructure, such as continuing healthcare assessments, maintaining safeguarding standards and meeting special educational needs. The majority indicated that there will be less ability to deliver on those standards, which is a concern. Given that the ICBs have said that there will be a reduction in standards, what assurances can you give that patients will not be cut by ICBs?

Jan Thomas: When we were going through the change, it caused disruption. If I am honest, at the time when we were filling things like that out, we ended up with different people in different jobs trying to merge organisations. I think it is fair to say that the delivery of some of those delivery functions of an ICB suffered as we drove the change.

When I talk to my ICB colleagues now, what we have all done as we have gone through that change process is settle down and make sure that we have the right people in the right places, especially when it comes to safeguarding continuing healthcare, who are our most vulnerable residents in our communities with the highest need. That is to make sure that we have the resources in the right place.

There was a moment in time when we made the changes and it did feel quite messy, especially when people were taking voluntary redundancies and we were having to replace them in other roles that were associated with some of those core functions. But now it is not a question of reproducing that. Now that we have gone through the process of change, most places are settling down. I think that colleagues who speak to their ICBs will start to feel that settling down is either happening or has already happened.

  1.         Tristan Osborne: Would you be prepared to do another questionnaire in six months’ time on the same basis and for those results to be shared? If what you are saying is true, that data should change and there should be fewer. On that last point, paragraph 3.14 states, “There were other areas where ICBs considered they had received ‘somewhat insufficient’ or no support”. Interestingly enough, it also says “including information on their future role” and on “the rationale and objectives of the restructuring.” What lessons have we learned from that, given that why some of these organising bodies are being restructured should have been clearly articulated from the start?

Sir Jim Mackey: First, to go back to your earlier question, there will be a post-evaluation framework, which should wrap up your question into one process rather than having multiple processes if we can, in terms of thinking about work for colleagues.

If you look back at the whole thing, a lot happened in a short space of time. It felt very chaotic at times. We were trying to work out what the rules were. All the service was effectively upside down. Again, as a reminder, we were starting the year with a £6.7 billion gross deficit, and that is not going to be easy to address quickly.

In an ideal world, all of that would have been fully documented and agreed and everything would have been in place with the Treasury beforehand. A redundancy scheme would have been agreed and in place, and there would have been the ability to communicate with colleagues in a normal manner over a period of time. We did not have that luxury because of the way, through necessity, that it all happened. All year, it felt like we were trying to recover from that, and we were all very conscious of making sure that we did not drop the ball.

As you rightly pointed out, as the year went on, I remember doing some really awful meetings with colleagues where people were very upset and worried. There were quite low levels of confidence in getting there at times, as we went through the year. In the last few months, that has changed quite dramatically, and people are now feeling much more on top of it. It is absolutely not perfect, but if you look at that change process over what is broadly 18 to 20 months, it is absolutely massive—the number of people who have left, the changes to the operating model and discussions about other changes in the architecture. It is all right changing one bit; you have to try to make sure that it fits with everything else.

It is actually quite hard to remember the sequence of events and how it all panned out. In all that, I would say that it was unnecessarily difficult for the colleagues involved in it all, but the NHS has largely managed to pull it off. We have delivered big savings, made a big cost reduction, delivered what we said we would do financially at the end of the year and delivered on our performance metrics at the end of the year. We have all got a lot still to do; we are nowhere near where we want to be, but I think it is incredible for colleagues in the service to have managed to pull that off through all of that.

  1.         Tristan Osborne: Thank you for your candour on some of those challenges. My last question concerns your future savings projections. Obviously, I have raised concerns about how many organisations have already presented their target operating models. I think you have articulated the challenges there. I have talked about future redundancies, as has the Chairman. We are going to ask for the detail on the ICBs. How confident are we, rationally, that we will see these changes, or are we going to see a slow erosion of that savings figure over time, perhaps because these organisations are using consultants or they are re-employing these people?

Sir Jim Mackey: First of all, we are going to trust people. We are trying to set up a system that is rules-based and built on boards doing what they need to do within the rules and frameworks and all that. We have got all the normal assurance processes in place. We rely very heavily on “comply or explain” in the health service; it is a large organisation where you would expect boards to take responsibility and to flag if they are not going to be able to meet the future commitments and responsibilities. We will periodically keep track of this. We will watch the metrics. We are very close to these organisations. We are talking about them as though they are people we do not know and as though they are on a different planet, but we see them all the time. I am seeing them again on Thursday with other colleagues. We are in regular contact. We are all over the numbers, and if we start drifting out, we will be doing something about it.

Elizabeth O’Mahony: At the start of the year, we effectively reduced their budgets by £900 million, so it is not there for them to spend; they would be overspending. To give you clarity, we have reduced their allocations by £900 million recurrently.

  1.         Tristan Osborne: My worry is that, as Clive said, you are reducing their budgets. They are already giving answers to say that this is potentially impacting statutory frontline services, and as you said, there has been a lot of change in a very short period with a lot of organisational instability. What I am trying to get from you is confidence. Are you confident that we are not going to see a fallout from this process, where one ICB will ask for more money from you or try to get deficits?

Sir Jim Mackey: Yes, I am confident about that—as much as you can be in the health service—but you are right to flag it. Part of this is the fact that, when ICBs set off, they had running costs of about £1 billion, and then, within a couple of years, it was £2.2 billion. That is partly why this had to be corrected. It had grown and it had got out of control. We need to keep an eye on that, the regional and national leadership need to keep an eye on it, and most importantly, ICB boards need to keep an eye on it. They need to make sure they are spending their money wisely locally. All this is built on boards doing the right thing, and we talk about that too little. You can build a national assurance system and keep asking people for returns, but we need boards to do their jobs.

  1.         Chair: You have promised us a note, Jim, but I have two further questions on redundancies. The first is: how will you ensure that having made all these people redundant, the numbers of jobs and staff are not going to creep up again?

Sir Jim Mackey: I think I wrapped that up in my last answer—that is what we are seeing. We have very clear expectations. We will keep an eye on people. We will get periodic returns. We will be looking at the forward plans, but also the results every month and every quarter, and through the oversight framework, we will keep an eye on that, but we need boards to own that. We need boards to make sure they are spending every pound wisely because money is tight. It is tighter now than it was when we set off in this process. The fiscal position is much harder.

  1.         Chair: Okay. My second question on redundancies is, how will you be sure that, having made quite a large number of people—8,200— redundant, you do lose critical skills? The Report refers to a loss of clinicians in some ICBs. How can you be sure you will still have the range of skills in all the ICBs to operate effectively?

Sir Jim Mackey: That is wrapped up in our assurance from ICB boards when we say, “Are you able to perform your functions with a reasonable level of confidence?” We are keeping it under regular review. It was a big part of the challenge and discomfort last year; some of our worst meetings were about whether we were going to lose things. Generally, NHS people are very passionate about what they do. There is a lot of concern that we would drop the ball, disable something that is attached to something very important and regret it later. So far, colleagues have done an absolutely fantastic job on that, but we cannot take that for granted. We will have to keep an eye on it all the time. Importantly, it is a board’s job to make sure it has the capacity and capability to perform its functions.

  1.         Chair: We will take a break after the next few questions on the merger of NHSE with the Department and its effect on ICB restructuring. It seems that ICB restructuring is going faster than the merger. How will you make sure that the two processes synchronise properly with each other?

Sir Jim Mackey: We have been trying to do that throughout. There have been times when it has felt like it is all neatly dovetailed together, and other times when it has not. In terms of the national processes behind this, a lot of people have left NHS England under voluntary redundancy but, as we have discussed before, there have been delays in our operating model. The Secretary of State’s announcements a couple of weeks ago have allowed us to cut through on all that.

In terms of our national oversight, a key part of the job of the mechanisms that we use nationally to keep an eye on things—the project boards and the mechanics that serve as the change process—has been to flag and identify where we have said something in one place that disconnects with something in another, and occasionally we have had to go back around that to adjust and refine something. That process happens every day. We are all very aware of the risk of stopping delivering on something really necessary.

  1.         Chair: Have we got to a settled position on exactly what functions you want ICBs to carry out now, and on what else is doing all the rest of the functions?

Sir Jim Mackey: I will bring in Jan in a second, but I would say, “Settled, but—”. I am a big, strong believer in the devolution philosophy, in principle, and in localisation wherever possible. The hesitancy in my voice is because I do not think we are fully maxed out on that. We are not fully maxed out on the contribution of the NHS with other local partners and on what we can bring to this. On the NEETs issue, the anchor institution contributions that we can make, or whatever the issue is, the NHS can bring more to that. As we get through it over the next couple of years, working with strategic authorities, local authority partners and central Government colleagues, we might find more opportunities where something has to be aggregated or devolved from the centre to support that principle. The Secretary of State is also pushing us really hard on this to make sure that we are fully leaning into it. All I am saying is that none of us know quite where that is going. There is no guarded, under-the-table message that there will be another reorganisation in six months; it is just a really different way of looking at things, and not everyone has got their head around it yet.

  1.         Chair: Jan, do you wish to add to that?

Jan Thomas: I think it is changing. When we did the blueprint, even that said, “We will need to test whether this is right, what needs to stay where and how.” The blueprint was quite clear that it was not a case of, “These are the services that are in, and that are out because they were devolved.” Not only do we have to do things differently as ICBs, but people have to be ready to receive and do them differently, as we talked about with transformation.

This is much more of a change process and evolution; it has happened over the last 12 months, and it will probably keep going, especially for things like the digital agenda, where we now work far more collaboratively with our providers. We say, “This is the direction we need to go in,” but we work with them on the delivery. We can set direction and outcomes, and they can really focus on the delivery. That will keep changing over time, with different parts of these functions. I can go through what we think sits where, but we are literally learning and doing that in collaboration, in a way that we have not done before. It was quite black and white, but now we are really trying to do this as a collective, which I think is huge progress and why the ICBs are so positive.

  1.         Chair: I was not going to come on to digital just now, but I will since you raised it—you would expect me to ask you about it. Data seems to be everything at the moment under the modern digital systems, as is the ability to apply AI to that. I may be wrong, but I was a bit dismayed to see in the Report that it appears the ICBs will collect less data than they have before. Is that true?

Sir Jim Mackey: The data collection has not really changed, because most patient-level data works in a system that is almost independent of all this. The way I see this, as Jan described, is that the NHS nationally sets out that it needs certain levels of capability. Patients should expect certain levels of data exchange and functionality—the ability to book appointments, what the app can do and so on. You would expect strategic commissioners to make sure that they make commissioning decisions and contract with organisations that can do that and know they have to do that, and providers have to make sure that that capability is deployed. This process is still working out.

If all that is true, what is the best level to do it at? What is the most cost-effective way of doing it? Providers are saying that they want to move much more quickly than we can currently allow them to because it is still quite a centralised process. But if we just say, “We’re going to devolve it all overnight,” there could be chaos. In this complicated change process, we are trying to work out what the role of an ICB or strategic commissioner is in that context, versus what is regional. It would be really easy to say, “We’ll just devolve all the resource regionally.” I would much rather it was devolved in the payment mechanisms so that providers were getting paid for it. We have determined nationally what is necessary, but that whole operating model is actually quite different.

Chair: It is not a subject for this hearing, but I am sure we will want to come back to digital connections in the NHS. Thank you for that answer. We will take a short break now. The clock stands at almost 4.45. Can we be back here promptly at 10 to? We still have quite a lot to get through. Thank you for what you have done so far.

Sitting suspended.

On resuming—

  1.         Matt Turmaine: I would like to ask about capacity, capability and skills. As the Chair said, we have touched on some of these issues already, Jim, but could you tell us how you are managing the risk that the restructure reduces the ICB’s capacity and skills? From what you said earlier, in terms of how far you have progressed through it, you may be talking about how you did manage it as much as how you are managing it now, but you get the sense of what I am asking.

Sir Jim Mackey: We had mechanics in place through the year, such as the model ICB group and the operating model steering group, and we had regular discussions with regional colleagues and regular interactions with ICB colleagues. We met ICB leaders in person several times last year, and all that sat alongside all the normal returns, projections, compliance reports and so on. Jan has picked up that role as well; she is working actively on the oversight framework to make sure we are confident that the board capacity and capability is in place.

We also reconciled that with other interactions with the system. We did quarterly reviews and star chambers at the half-year point to check where regions were at that point and how confident they were about their projections. We then did specific deep dives into specific localities where there were known issues, where concerns were expressed about the change process or where they had lost key people. Sometimes this is about macro maths, but it can also be about losing two key individuals who decide to go. I remember an awful lot of conversations over the last 18 months or so that went, “We are going to lose person A, who is taking VR. They have kept this place going for the last 18 or 19 years.”

There is a set of mechanics, and there is watching the numbers, templates and assurance reports. Then, there are the more informal, personal interactions and the cross-checking. Those can include things like Clive’s challenge on his South Yorkshire experience, and talking to other political colleagues about whether things are working, what they are experiencing and whether it is going according to plan or in the way it has been described. It has been all those things put together.

  1.         Matt Turmaine: There has been an awful lot of change over the last 10 or 12 years—from CCGs to ICBs and now to this. Are you confident that you have been able to address those challenges as they have come up, in an effective and timely way?

Sir Jim Mackey: I think so but, again, it has been a really big and rapid change. In my career, I have not seen anything like it in terms of the scale and the pace; the amount of change that had to be done was quite breathtaking. We all felt the pressure at the beginning of last year to get this done as quickly as we could, because generally the quicker you can get in and out with these things, the better it is for everybody.

Overall, that has worked relatively well in the context—accepting that there is a price for the individuals and that there was an awful lot of worry as we went through the process. We have also had an awful lot of regrouping—checking whether this or that is right, and asking whether this is actually going to work or whether we need to go back a couple of steps. That has been pretty active and is ongoing. It does now feel that we are in a different and distinct phase. ICB colleagues were saying last week, “We have just about done it. It has exposed some gaps, so we have a bit of recalibration to do, and we need to do that with you over this next period.”

Jan Thomas: As I said before, we cannot assume that it was working well and now that we have changed it, it is not working. There were things that we needed to improve before. I could not agree with Jim more that the effect on some of our staff was profound. We have had to handle that very carefully. Now, the investment really does begin in their skills and capabilities, with the strategic commissioning development programme, which we are running over two years. That will not just give ICBs some development, and really focus on the delivery of things like the neighbourhood health agenda and everything from the health actuarial analysis we need, through to how we get that implemented. That strategic commissioning development programme is a deliberate central investment to make sure we can work with those teams on the ground to make sure they are not just keeping capacity and capabilities, but building new ones.

  1.         Matt Turmaine: I have a question on redundancies. I know that you are going to provide a note, and it may be that you can just fold this into it, which would be fine. Are you looking at the percentages of people who have left or been made redundant from the ICB because a function is no longer required to be done by the ICB?

Sir Jim Mackey: I do not think that we collect at that level of detail.

Elizabeth O'Mahony: Anyone transferring was not assumed to be an efficiency unless, when they were transferred into the transferring body, it was done at a reduced cost in aggregate. It is not part of the savings. Nobody was made redundant where they were transferring. I do not have it with me, but I have the number of people that transferred as part of the exercise. We could provide that in the note.

  1.         Matt Turmaine: That would be great. My final question for the moment is also for you, Elizabeth. Have any additional moneys been provided to ICBs for functions that have gone into their responsibility?

Elizabeth O'Mahony: No. When we did the exercise and we moved to a new population figure, which essentially now increases pay, as Jan described, there were a number of functions for which we said we would look at whether or not they would be retained. That was taken into account at that point, so no additional funding has gone in. We have also seen enhanced clustering, so there have been economies of scale where people have done some of the functions on a bigger scale.

Matt Turmaine: That is great. Thank you very much.

  1.         Mr Betts: I will come back to some familiar issues about the connection to local government. Sir Jim and the permanent secretary have referred to the need to reduce in ICBs the number of staff who were not patient-focused or immediately hands-on. Is the same reduction going on at the centre of NHS England and the Department?

Sir Jim Mackey: We have been under very similar headcount-reduction objectives in the centre as well, Clive. That is ongoing and we are broadly on plan as well—so absolutely.

  1.         Mr Betts: So there are percentage cuts in central overheads.

Samantha Jones: I think we will come back and confirm properly with the Committee when we get to the year end, if you are comfortable with that.

I just want to go back to the point that was made about reducing duplication and making sure that we have a sense of purpose about what the roles of a region and an ICB are, what the role of DHSC will be in future, and what the role of NHS delivery is through that. That has driven the changes. I echo, as I should have done at the beginning, that we recognise—and have already apologised to people who have been going through this—the amount of time that this has taken.

To go back to your question, Clive, we will confirm with you the actual numbers. Overriding this, and as you know from the Secretary of State’s letter, is what the purpose of the new DHSC is and how that will be executed in practice.

  1.         Mr Betts: Let me come to the connections at a local level. I appreciate that we had a long discussion about the Sheffield and South Yorkshire position, on which you are going to come back to me. A question has been raised across the board about the fact that, around the country, there are lots of examples of a history—a good history, generally—of joint commissioning between local authorities and the health service, which the ICBs were involved in, and the feeling now that there often isn’t anyone in the ICBs to carry on that work, because they just don’t exist. Are you picking up the need to address that generally?

Sir Jim Mackey: Jan will come in, but we talked about this specifically last week. There is a natural feeling of loss in some places where they had, as one ICB colleague described it, almost mini-organisations in place, where colleagues worked very actively together, but it was a very, very expensive model. The change process has changed that. There are still people whose responsibility it is to work with those councils, but it is a different operating model. That takes a bit of time to settle down.

I spoke at a conference on Thursday and met a group of social care directors separately afterwards. There was an observation that it felt a bit like when they went through austerity and councils really shrunk. It took a while for that to settle down and for them to work out who to speak to. I think we are in that kind of process.

Jan Thomas: I think it is settling down now that we have people in place, and so on. There is a question of what we do locally and what we do at scale. Some of the stuff that we had been doing locally in ICBs we are now doing at more scale, to make it more efficient, but that does not take away from the people and the place teams that we have on the ground.

Perhaps I can talk about my own ICB for a few seconds. We have 3.5 million people and seven different local authorities. We call that “place”, so we want to make sure that that works for place on the upper-tier unitary authority level. But when we do plans, that does not mean that we do seven different plans. We have examples lately of how we did not ask for one SEND plan across the ICB; we did seven individual plans with each of them to make sure that they were configured with the places we were working with and the local authority. I do think we are adapting to make sure we are still doing that localism but, undoubtedly, if we can get scale on some things we are taking advantage of that, because we have to within the running cost changes.

  1.         Mr Betts: Are concerns being raised with you by local authorities, social care directors and public health directors that more work is being pushed on to them because there are not the people in the ICBs to do it any more?

Jan Thomas: There is the change process that Jim explained, where we had some people in place and now we have different people in place, but it is less about—dare I say it?—the cost shunting; people want certainty of who it is. To make this work you have to have trust between the local authority, the DASSs and the leads for things like continuing healthcare. That is what we are focusing on. It is not about cost shunting; it is more about building back up those relationships.

  1.         Mr Betts: I asked a question: are concerns being raised with you by social care directors—

Jan Thomas: Not—

Mr Betts: So they are all happy that they are getting exactly the same degree of relationship with you as they had before.

Sir Jim Mackey: I am not getting letters or emails from social care directors. I met with a group on Thursday at a national conference, and what was described was teething troubles—they are still not quite sure who is doing what; things are sort of settling down—but specifically, Clive, I have not had lots of letters or angry emails from people saying that something terrible has been disabled.

There is a group of council chief execs I meet, usually about once a quarter. In my first two meetings with them last year they were understandably very unhappy, because we had turned their worlds—one of their main partners—upside down. The last time I met them, they were mainly bothered about local government reform, and they could see that our part of the world was starting to settle down. They were much more bothered about what was going on in their own world. They are generally people who are not shy in coming forward with concerns and things that need to be addressed, but I am not sat on a pile of letters in the office, or a bunch of emails unread, that say, “This is a disaster and you need to sort it out.”

Mr Betts: Maybe after this conversation it will change and the letters will start to arrive.

Sir Jim Mackey: You are our most prolific complainer, Clive—you win that prize.

  1.         Mr Betts: Clearly, local authorities have raised concerns about the statutory safeguarding responsibilities. They are a function that the ICB has to meet, along with local authorities—there are requirements for them to do that together. There are complaints that there now are not enough staff to deal with all the local authorities that need these safeguarding arrangements in place; the ICB staff are stretched too thinly, and it is not really working. Is that fair? That is what was fed back to us.

Sir Jim Mackey: Jan should speak up, but I think the NAO Report says that there were concerns that that might happen at a point in time when people were asked about it. It certainly was not raised as an issue last week, when we discussed this with chief execs.

Jan Thomas: We have statutory accountabilities that we have to fulfil for safeguarding. I do that alongside my local authority and police colleagues. We take that very seriously, as do our boards, and we have governance through our organisations to make sure that we are discharging our duties as we should. The changes we have gone through mean that people are dealing with different people. We have covered it before: the change of people was destabilising, but I do not think that any board or any chief executive does not feel, as they should, the weight of making sure that we have our safeguarding right, because that remains with us as a statutory function.

  1.         Mr Betts: So there are not any problems in that area at all.

Jan Thomas: I can’t say there are no problems anywhere, but—

Mr Betts: No problems have been raised with you.

Sir Jim Mackey: They have not been raised with us, Clive. If they had been, they would have been dealt with. Safeguarding is one of those things that is very multi-agency. There are really well-established processes, and that would be something where, if it was not working, we would absolutely be hearing about it, really quickly.

  1.         Mr Betts: The Royal College of GPs—I accept that perhaps they have an interest in this—have said there has been a “loss of clinical leadership within ICBs”. Certainly when I used to meet the place teams—through covid that was invaluable—there was a medical director and a number of clinical directors, and most of them were working GPs. They could talk about their personal experiences and their understanding of what the policies and procedures meant in practice for the people actually delivering the service. That has gone, hasn’t it?

Jan Thomas: It is interesting. When we were CCGs, they were clinically led, GP-led organisations; I sat on a CCG board, and GPs and clinicians were the majority on those boards. As we moved to ICBs, that changed. We went to medical directors and chief nurses to lead, and then people to lead programmes. In the new iteration of ICBs, everybody has strong clinical leadership. What they call them and what they do might change. For example, I have somebody who leads on our utilisation and clinical quality, and they fulfil my medical director function but are not called medical director. It is a little bit of semantics, but clinical leadership is still at the heart of ICBs, although it is not what it was when they were CCGs; that is different.

  1.         Mr Betts: Do you think there has been a loss there, in that people with immediate, first-hand experience are not having input into how things run?

Jan Thomas: I think it is very important that we have ways to make sure that the clinical voice is through everything we are doing, and that is what we are doing.

  1.         Mr Betts: How should those ways operate? What are they?

Jan Thomas: We talked a bit about this earlier, with regard to the pathways. We are working much more with our providers and provider networks and using their clinicians to drive the change. That is happening a lot more. We have collaborative things, like the cancer collaboratives and the networks, that still keep all that clinical engagement in place. Also, we now work very closely with our primary care networks, which are absolutely valuable. We all invest and work with them to make sure that we are still hearing the voices of GPs. So we do a lot of work to make sure that we are doing that through numerous different levels.

  1.         Mr Betts: You have answered the second question I was going to ask. Sometimes providers are thought to be hospitals; actually, it is important—probably more important sometimes—to engage with primary healthcare as well.

Jan Thomas: And it is not just GPs. The role of community pharmacy is fundamental, as are hospices. All of these are the clinical layers that we are talking to. Again, just as an example from my own board, we have a community pharmacist that sits on the board along with the GPs and so on. Primary care in the round is really important.

  1.         Chair: Before I go to Anna, I want to probe this a bit more, because several of the submissions in response to our call for evidence, which you may have seen, stress that integrated care relies heavily on relationships between ICBs, providers, local authorities, clinicians, and voluntary and community organisations. You have stated that your own ICB is 3 million people. How are you going to preserve that accumulated knowledge if people are no longer there to implement it?

Sir Jim Mackey: What we are saying is that that does not all have to live through the ICB construct. Throughout my time in the NHS, primary and secondary care working with local authorities has been an important thing. It will always be an important thing. There was a period in this where it was very much a primary duty or felt like a primary duty of an ICB to do that, but it has to happen elsewhere. The pathway stuff is absolutely about clinicians working with each other: between primary and secondary care, the multi-agency stuff, the NHS—primary and secondary care and community services—working with local authority colleagues, and so on. What we have done with this is say: “That should all still happen, but don’t route it all through the ICB formal infrastructure.” It might happen through a provider collaborative, through some neighbourhood arrangements—there are lots of ways of doing it. And there have been other times, pre ICB, when we have done this really well.

Chair: I think we may want to reflect on that, and I am sure we will hear from people out there what they think about it, but we will see.

  1.         Anna Dixon: I will follow up the point on GPs, if I may. Figure 6 in the NAO Report shows that ICBs have retained “General Practice IT” and “Primary care operations and transformation”. You have said you did not have any letters of complaint from local authorities. I think you might be getting some from GPs, including one of mine. The description of what has happened with the changes at the ICB is pretty shocking. Words like “chaotic” have been used, and certainly there is a failure to have a functioning IT system. Nobody now seems to respond. There were delayed payments, which effectively impacted cash flow for the general practice. I think this is the point about not having named people to deal with any longer at the ICB. When you are a general practice, you are relatively small. It is a lot of organisations for the ICB to effectively manage.

Can you give me any confidence about the engagement of general practices directly and that those functions that are retained by the ICBs are being discharged effectively?

Jan Thomas: Things will vary, and I am more than happy to take details of where it has not worked and pick that up with colleagues, because I think that is important.

The way we need to keep thinking about this is that, previously within ICBs, if you think about a spectrum between scale and hyper-local, we ended up in the middle of that a lot of the time. Now, as ICBs, we do quite a lot at scale, but we are very much focusing on the hyper-local as well. Most places—I am very happy to pick this up offline—have key named place teams and leaders, where people can go and talk about things like the neighbourhood health work and how those pathways are being integrated.

For GP IT specifically, we also have some complications with the commissioning support unit changes and what is happening with those. GP IT specifically has been difficult. It goes back to the point about multiple things changing all at once. That is different from how we are working with GPs on a day-to-day basis on things like services and improvements that we are making—GP IT sits slightly differently from that.

  1.         Anna Dixon: I appreciate your saying, Jim, that these relationships can exist outwith the ICB but, in terms of wider collaboratives, the history is that they tend to be dominated by the acute hospital trust. What confidence do you have that in those relationships there will be a strong enough voice for primary care and community services and that we will get the shift to community?

Sir Jim Mackey: It is a really good point. We have emphasised this in the overall leadership community. We have been considering whether we should send a signal in the oversight framework for providers generally about demonstrating how to work together. It is very hard not to default into drawing on my own experience in Northumbria, and then a bit in Newcastle when I went there—certainly from 20-odd years in Northumbria—

Anna Dixon: You were quite a unique leader.

Sir Jim Mackey: I think there are others around the country who really are putting a lot of effort into those primary and secondary care relationships. The PCN development is actually useful for that, because it tidied primary care up so it was easier to engage with. Sometimes it is quite hard to engage with it; it feels quite disparate at times.

Through all this, whether we are talking about neighbourhoods or frailty—in all the things we are talking about all the time—it is all very dependent on every part of the system working together. We need to talk more and help people understand better what works around the country and how to go about that, and help educate young leaders and people coming through that it is a core part of the job.

As I think I have said here before, I always felt as a provider chief exec that it was my job to engage with local authorities, with primary care, with the mental health system and so on. I might have been running an hospital—I was running community services as well and a bit of primary care over time—but it was my job, our job, to work with partners. I think we just all need to get into that space as best we can.

  1.         Anna Dixon: It sounds like you have done a lot of engagement with different stakeholders who clearly do have a view on how this is going. I just hope that you would include general practice leadership—not just the RCGP but those who are working in LMCs.

Sir Jim Mackey: Absolutely. Jan and I and a couple of other colleagues are meeting a group of at-scale primary care providers this week to talk about out-patients and how that might change. They join our national chief execs event every quarter as well, so we have primary care leaders in there. They would normally have been NHS trust and FT leadership events. We are trying. It is a journey.

  1.         Anna Dixon: My other question builds on what colleagues have asked about. Figure 7 on page 29 sets out where you were in May 2025 with the model blueprint, and a whole set of functions that were looking at being transferred, variously, to providers or NHS England regional teams. All of those listed are retained. My colleague Clive touched on safeguarding, but you also have continuing healthcare, special educational needs and emergency preparedness in there. These are very important functions. As was previously mentioned, they are quite operational and clinically important functions, yet the assumption when the headcount amount was specified was that these were not to be retained.

Has retaining these functions and therefore, I assume, retaining a skillset and capacity of people resulted in any adjustment—upwards, in this case—of the amount per capita that ICBs have to fulfil functions that at the time, in May, were not going to sit with them?

Elizabeth O'Mahony: In the model ICB work, these were functions that were to be discussed; they were not necessarily going to be transferred. They were functions where, jointly, ICBs and NHS England colleagues said, “We should think about where these are best delivered.” At the start of the exercise, there was a notion of a 50% headcount reduction. We have not pushed to achieve that. It is actually at 43%, I think, so there was some slippage there that has been played in.

To enable some of these functions and others to be done at scale, we have also looked at how we would achieve this using hosted services within regions. There is a mechanism where we have had further efficiencies, which we were not assuming at the start of the model blueprint exercise. As Jan says, it has evolved as we have gone on.

I will not quote people, but we heard really clearly from ICB colleagues—chief execs—last week that they had sufficient funding to deliver the statutory duties and core functions. They said that, in some places—going back to what Clive said—relationships need to develop so that people know who the relevant people are, and that the trust needs to develop. But there was a confidence there.

  1.         Anna Dixon: Is anything being monitored—for example, delays in EHCP sign-offs? We know that SEND reforms are coming in. There has constantly been a question about whether the NHS is delivering what it needs to as part of that. Also, are any delays happening in continuing healthcare decision making? We have talked a lot about how you are monitoring the benefits, but how are you monitoring to make sure there are no adverse delays to these critical statutory functions?

Jan Thomas: We have mechanisms in place at our board to make sure, and to track our functions—what we are doing and how we are doing in our performance.

Anna Dixon: At your ICB board?

Jan Thomas: Yes. At a board level, an ICB will do things like checking its performance on 28-day compliance on continuing healthcare. We have the robustness internally. Back to Jim’s point about holding boards to account, that is where we are held to account, through things like our performance committee, on not letting things slip because of the changes that we have had. Where they do slip, the board then calls us up through our sub-committees to make sure we have clear improvement plans in place. Some of that could be because of the change, but most of it is just because these things—like the 28 days—go through cycles of performance.

  1.         Anna Dixon: You would not have to flag or report if you were outwith that.

Jan Thomas: If my 28-day performance goes off as an ICB, my regional colleagues are very kind at pointing that out and asking what I am doing about it and when it is going to improve.

  1.         Matt Turmaine: I would like to talk about local government reform. The Government have their local government and devolution agenda, and all the changes going on with ICBs have been taking place during the same period. Obviously, there is an ambition to have ICBs coterminous with the mayoral strategic authorities by the end of the Parliament. What are you doing to make sure those things align?

Samantha Jones: At the risk of repeating myself, one reason for the transitional special health authority is to make sure we are working closely, and at the speed required, to deliver the devolution agenda set out by the PM. As you know, there is a clear stated ambition that there will be alignment between mayoral authorities and ICBs by 2028.

What is important—we can come on to the detail—is that some of those ICB structures were halted to make sure they were going to do what needed to be done. That has been difficult for some of our ICB colleagues, and I am sure colleagues from NHS England will pick that up, but that is the reason for some of those delays and that is the stated ambition.

In terms of the reason for that, I just want to go back to a question that Anna asked. Health and wellbeing boards are also a place for collaboration and local partnership arrangements, including agencies, both voluntary and statutory, outside of the direct NHS as well. That is clearly one reason to make sure people are focused on their local place, people or communities.

  1.         Matt Turmaine: That is very helpful; thank you. Do you think the timeframe is deliverable, because 2028 is not that far away? There are big changes. I appreciate that the ICB changes have been going at pace, but the LGR stuff has been subject to a pause, a restart and so on.

Samantha Jones: We had a very clear steer from the Prime Minister and the Secretary of State that that is the timescale we will be working to. The important bit is making sure we understand the boundary issue and how it works in practice. But yes is the short answer to your question.

  1.         Chair: My ICB was merged in an awful hurry, long before anybody knew in which direction Gloucestershire was going to go for strategic authorities. If Gloucestershire went in a different direction to the now merged ICB, what would happen? Will that ICB have to re-merge with somebody else?

Jan Thomas: When we know more about the strategic authorities and the complete boundaries, we then need to work out what will be the best fit. In some cases, that will be a clear one to one. In some places, we will have to do some boundary changes to make sure a mayoral authority has to work with only one integrated care board—that is true. Part of the reason we wanted to delay a little bit is that we did not want to do that. The ICBs in, say, Gloucestershire have grouped rather than done the full merger. We have halted a full merger so that we do not make changes now that we then have to undo in terms of a formal organisation being created. There is a difference between working as a group and having a single leadership team, and actually closing down a statutory organisation and opening up a new statutory organisation. They are different things.

Samantha Jones: In answer to your question, there is a risk that that might be the case, but certainly from a national perspective we are doing everything possible to minimise any further disruption to individual ICBs, and making sure we deliver what needs to be delivered. So, yes, there  is a risk, but we are making sure there is a pause, in order to do this as quickly and safely as possible, while not losing what we are really trying to do, which is to take things as local as possible.

  1.         Chair: Okay. Can we talk about the target cost per head of population for ICBs? Your original target is, as far as I know, still £18.76 per head. That is what we are told in the Report. That is against a baseline average of £32.98. That is what these reforms are supposed to achieve, are they not?

Elizabeth O'Mahony: It was originally £18.76, as set out in the Report. There have been pay awards, so that is £19.60 per head after pay awards.

  1.         Chair: My ICB has the unfortunate accolade of being the highest per head of all in this Committee, at £44.80. The baseline was £32.98, but isn’t it a fact that the costs of providing health in rural areas are higher than in urban areas? That is for two reasons. You have all the distances to be covered—you are delivering services at distance—and there tends to be a correlation between rural areas and a higher age demographic. Will there be any allowance for ICBs that have higher costs?

Elizabeth O'Mahony: The cost of £19.60 is the running cost of the ICB itself, not the delivery of healthcare, so that should not be a factor.

  1.         Chair: It says in this table, “Baseline ICB spend per head…Gloucestershire…£44.80.”

Elizabeth O'Mahony: That is the running cost of the ICB, not the delivery of healthcare.

Chair: Right.

Elizabeth O'Mahony: That is the administrative and commissioning costs of delivering healthcare in Gloucestershire. They had more staff, essentially, and a higher overhead. Therefore, in comparison with one of the ICBs in the north-east, to move from their target to the reduced target of £19.60, they had the furthest to travel. Some of that would be taken into account in considering the fact that they merged with BNSSG.

  1.         Chair: How are you going to take into account those additional costs in rural areas like Gloucestershire?

Elizabeth O'Mahony: The cost of delivering healthcare within rural settings is taken account of in the allocations. Sorry, I am not describing it very well. You have the running cost envelope, which is £19,60. As a shorthand, that is essentially the administrative cost of supporting the delivery of healthcare. Then there is the actual allocation for the population of Gloucestershire. That is adjusted within the national formula, which is delivered independently by ACRA. That accounts for rurality.

Sir Jim Mackey: Also, Geoffrey, the lowest-cost ICB at the beginning was North East and North Cumbria, which has Northumberland, Cumbria and County Durham in its footprint, all of which have very dispersed populations. There is not really an argument that running costs are affected by rurality. Core service delivery is, but not the running costs.

Elizabeth O'Mahony: And the allocation for service delivery is adjusted for rurality, age and deprivation.

Chair: Okay. I think we have more or less come to the end, unless any colleagues have any further questions.

  1.         Mr Betts: Sir Jim, you were quite open about the challenges and problems that the reorganisation caused for the whole organisation at the beginning. Are you really saying to us that if you had your time again, you wouldn’t reorganise it in this way?

Sir Jim Mackey: I was absolutely convinced that the layers between delivering services at a provider level and the national level—the Secretary of State, effectively—had become very confused. There was lots of overlap, and it was very expensive. If I was presented with the same facts again and asked to make a decision, I would still reorganise that. It would still need to be made leaner, clearer, more rules-based and more cost-effective.

What I was trying to express earlier is that, in an ideal world, we would have gone about it differently. We would have communicated more effectively and got all the approvals lined up before things were communicated. The big pain barrier last year was the delay on trying to agree the funding for voluntary redundancy and the mechanism by which it could be done. That was beyond everybody’s control. I would absolutely seek not to do that in this kind of change process, but there isn’t a world where I would have left it all as it was. It was very confused and expensive, and it was very hard to see who was making what decisions. There were times when there were multiple layers of performance management.

To come back to the earlier point, if we had not done that, we would have had a huge financial problem in addition to our other cost pressures last year. It would be even worse this year, going into next. There was a financial imperative that we need to accept and lean into.

  1.         Mr Betts: So the message is that it needed doing, but it might have been done better.

Sir Jim Mackey: We could have absolutely done it better. We all expressed our sympathy and compassion for those involved. These are colleagues that I have worked with before. They are friends and other colleagues’ friends. Watching what it was doing to people—the worry, the concern, the anxiety, the uncertainty—was awful all round. That was for colleagues in NHS England and the Department. In this part of the infrastructure, you absolutely would not want to do that.

Generally, the evidence on big change shows that you should do it as fairly as you can, as quickly as you can, and you should allow people to come out the other end as quickly as possible. We didn’t manage to do that. We did our level best, but we didn’t manage to do that. That said, the service has managed to reorganise to a huge extent, release an awful lot of money, clarify decision making and implement an operating model, while at the same time delivering an eye-watering cost reduction and financial correction in-year, and largely delivering our performance objectives to the year just gone. At the beginning of last year, I would have taken that.

  1.         Anna Dixon: I think you said earlier, Sir Jim, that this made things unnecessarily difficult. I just wondered what you meant by that.

Sir Jim Mackey: Just the delay and the confusion. This is a hard change, as we have discussed over the last couple of hours. There are a lot of moving parts, a lot of anxiety and an awful lot of risk. We have not talked about risk much today, but what colleagues effectively all do in these jobs is collectively try to manage risk. I would have liked it to have been quicker and more seamless, without the delays we have had. It felt like that could have all been organised. It was not, and it could not have been at a tougher time. That is what I meant, Anna.

I am not apportioning blame to anybody; it was a huge thing that happened very, very quickly. You can see the other argument as well—that the NHS only responds when something feels very urgent and very dramatic. I think that is a fair criticism at times, so you could see a purpose behind a short, sharp shock kind of approach, but it did feel very difficult for colleagues.

  1.         Anna Dixon: You have obviously managed a lot of that risk. What stays at the top of your risk register or—to ask it another way—what still keeps you awake at night?

Sir Jim Mackey: I always have a lot of things to worry about. At the moment, I am bothered about managing winter and ending the year well. But, primarily, none of us are happy about the standards we are delivering. Having patients in corridors is abhorrent. It should never have happened, and it has been allowed to happen over a period of time. We need to eradicate it as quickly as we can. I want us to be delivering constitutional standards quickly. I want patient satisfaction to improve more rapidly, but we are trying to deliver an awful lot of complicated things, in a big system, at a very rapid pace and in a very resource-constrained environment.

On that, I just want to recall again that I think what NHS colleagues have done in this last year and a bit is absolutely phenomenal. Nobody is saying we are delivering the best that we want to deliver and delivering the standards we want, but, my God, what a change!

  1.         Anna Dixon: I think we would all echo those thanks to colleagues who do these things. I suppose the evidence of past reorganisations is that it does distract colleagues from the task at hand. We have seen a drop in performance. In terms of readiness for winter, do you think that the same risk has materialised in this reorganisation, in that colleagues have inevitably had a distraction because they have been leading a very rapid change process, rather than staying focused on delivery?

Sir Jim Mackey: It is a good challenge, and the Secretary of State has pushed us really hard on this since she arrived. My view on the year so far is that we are winning, as super stats showed last week. We are there or thereabouts on elective care. The list has grown, but waiting times have fallen and we are just off the RTT trajectory, in spite of quite a big growth in demand. In urgent care, we are nowhere near where we want to be on any of the metrics, but again there has been 5% or 6% growth in demand this year. That demand is largely driven by better primary care access, which is a fantastic improvement for colleagues to have pulled off.

It is a distraction, and it has been a distraction for colleagues, but I do not think we can blame where we are on urgent care on the change process. I think it is much more that we have had a demand problem and a tough summer with heat, and especially problems with our infrastructure as well, that has taken a bit of time to recover from. We are absolutely all over winter. Winter is here. I had to mask up last week at a hospital visit, for the first time in a couple of years. So, it is here. We are living it now. We are managing it, and colleagues are absolutely committed to delivering what we need to deliver. It has been tough.

Samantha Jones: I just want to recognise and acknowledge our colleagues in the care sector. This is absolutely a joint team effort across the NHS and colleagues in social care and local government. As Jim said, they are focusing specifically on support through winter, but there is also all the work they have done over the last year to 18 months through the change.

Chair: Thank you all very much. There are still some really big concerns arising from this hearing, particularly around what cost savings this whole exercise will generate, the difficulty of redundancies, the co-ordination of all the local bodies with local authorities, and what services will be delivered by the joint bodies. It is clearer cut on the strategic authorities, because they will have people on the board, but it is less clear cut in areas such as Gloucestershire, which is not yet—it may well be in the future, but that may be delayed—a strategic authority. I think you need to manage that situation carefully in the meantime.

Thank you very much for giving us evidence today. We are looking forward to quite a lot of notes that have been promised on various different subjects throughout the hearing. We will be watching that but, again, many thanks. You have given us a lot of very interesting evidence. We will need to think about that and produce a Report with recommendations, which I hope you will consider very carefully. An uncorrected version of the transcript will be available in the next few days. Thank you again.